Cargando…
Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial
Autores principales: | Lear, John T, Hauschild, Axel, Stockfleth, Eggert, Squittieri, Nicholas, Basset-Seguin, Nicole, Dummer, Reinhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008063/ https://www.ncbi.nlm.nih.gov/pubmed/32104037 http://dx.doi.org/10.2147/CCID.S233097 |
Ejemplares similares
-
Tolerance of sonidegib after intolerance of vismodegib—Experience in two patients with nevoid basal cell carcinoma syndrome (Gorlin syndrome)
por: Venturi, Federico, et al.
Publicado: (2023) -
Nevoid basal cell carcinoma syndrome (Gorlin syndrome)
por: Lo Muzio, Lorenzo
Publicado: (2008) -
Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma
por: Dummer, Reinhard, et al.
Publicado: (2020) -
Nevoid basal cell carcinoma syndrome (Gorlin-Goltz syndrome)
por: Kiran, N. K., et al.
Publicado: (2012) -
Unusual Neurological Presentation of Nevoid Basal Cell Carcinoma Syndrome (Gorlin-Goltz Syndrome)
por: Pennisi, Manuela, et al.
Publicado: (2017)